Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
Determining the Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
3 other identifiers
interventional
50
1 country
1
Brief Summary
Demonstrate the feasibility of conducting an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started Jan 2025
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 20, 2023
CompletedStudy Start
First participant enrolled
January 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
March 12, 2026
March 1, 2026
1.4 years
June 12, 2023
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Acceptability of TiMBRe
mean scores for the Acceptability E-scale Items are ≥ 4/5
up to 8 weeks post start of intervention
Demand of TiMBRe
percent of patients recruited over three years
up to 3 years from start of study
Adherence to TiMBRe
percent of TiMBRe participants to complete the baseline and 8 weeks patient report measures
From enrollment to end of treatment at 8 weeks
Practicality of TiMBRe
percent of TiMBRe group participants self-report practicing music-based relaxation skills for at least 10 minutes on at least three days per week
From enrollment to end of treatment at 8 weeks
Secondary Outcomes (2)
Identification of facilitators and barriers to virtual TiMBRe participation
up to 8 weeks post start of intervention
Change in Anxiety management
at baseline and eight weeks post initiation of treatment
Study Arms (2)
TiMBRe
EXPERIMENTALan eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in AYA cancer survivors with clinically-relevant anxiety.
Attention-Control
ACTIVE COMPARATORStandard of care study staff calls and cancer survivorship resources
Interventions
1 \& 2 Music Listening * Live music played by the music therapist (e.g., guitar, voice) and AYA selected music will be used to facilitate attention to the present moment and provide cues for breathing/relaxation. 3 \& 4 Music Facilitated Breathing * The therapist will lead participants in music facilitated breathing exercises using rhythmic features of the music to cue structured breathing for relaxation and self-awareness 5 \& 6 Music Facilitated Progressive Muscle Relaxation for Stress Reduction * Using music as a structured auditory cue for tensing and releasing of muscles. 7 Body Percussion * The therapist will lead participants in a hands-on body percussion activity to bring attention to the sound of rhythm, sensation in their hands and body. 8 Participants Choice * will be selected by the participant.
Eligibility Criteria
You may qualify if:
- years old
- at least one month post cancer treatment
- report clinically relevant anxiety in the past seven days (PROMIS Anxiety 4a scores ≥ 55)35
- speak/read English.
You may not qualify if:
- prognosis less than 3 months
- documentation of significant hearing impairment
- plan to receive surgery, radiation, or chemotherapy for cancer treatment during the study period
- plans in place to begin new psychosocial (i.e., cognitive behavioral therapy14 or mindfulness-based stress reduction15) or pharmacological treatments for anxiety during the study. Although, participants may continue psychosocial or pharmacological treatments for anxiety if the treatments were initiated at least eight weeks prior to study enrollment, the dose has not changed, and they report clinically relevant anxiety in the last week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48118, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Knoerl
University of Michigan Rogel Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2023
First Posted
June 20, 2023
Study Start
January 21, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
March 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share